|
|
 |
CTNA Publications (updated April 2005)
Abi-Saab W, Cavus I, Spencer D, Sherwin R, Krystal J. Insights into the
relationship between excitatory neurotransmission, energy substrates,
and function in the human hippocampus: insights from intracortical microdialysis
and electrophysiologic studies in awake epileptic patients. Biol Psychiatry
2002;51:159S (#468)
Abi-Saab W, Maggs DG, Jones T, Jacob R, Srihari V, Thompson J, Kerr D,
Leone P, During MJ, Krystal JH, Spencer D, Sherwin RS. Striking differences
in glucose and lactate concentrations in brain extracellular fluid and
plasma in conscious human subjects. J Cereb Blood Flow Metab 2002;22(3):271-279
Anand A, Moghaddam B, Krystal JH. Effects of NMDAR antagonists: implications
for schizophrenia-reply. Arch Gen Psychiatry 2002;59:663-664
Balogh, S.A. , Keller, J.J., Picciotto, M. R., Paylor, R., Booker, T.K.,
Beaudet, A., Heinemann, S. and Wehner, J.M. (2004) Role of neuronal nicotinic
receptors in the effects of nicotine and ethanol on contextual fear conditioning.
Submitted.
Barnett, N.P., Fromme, K., Corbin, W., Borsari, B., Carey, K.B., Colby,
S.M., & Monti, P.M. Brief alcohol interventions with mandated or adjudicated
college students. Alcoholism: Clinical and Experimental Research, (submitted)
Basu D, Ball SA, Feinn R, Gelernter J, and Kranzler HR: Typologies of
Drug Dependence: Comparative Validity of a Multivariate and Four Univariate
Models. In press, Drug & Alcohol Dependence
Belger A, Fermaglich L, Vita L, Gore JC, Krystal JH. Event-related functional
magnetic resonance imaging of neural networks underlying cognitive interference.
Human Brain Mapping in revision.
Blumberg HP, Kaufman J, Martin A, Whiteman R, Gore JC, Charney DS, Krystal
JH, Peterson BS. Amygdala and hippocampus volumes in adolescents and adults
with bipolar disorder. Arch Gen Psychiatry 2003;60:1201-1208
Blumberg HP, Leung HC, Skudlarski P, Lacadie CM, Fredericks C, Harris
BC, Charney DS, Gore JC, Krystal JH, Peterson BS. A functional magnetic
resonance imaging study of bipolar disorder: State- and trait-related
dysfunction in ventral prefrontal cortices. Arch Gen Psychiatry 2003;60:601-609
Blumberg HP, Martin A, Kaufman J, Leung H-C, Skudlarski P, Lacadie C,
Fulbright R, Gore JC, Charney DS, Krystal JH, Peterson BS. Frontostriatal
abnormalities in adolescents with bipolar disorder: preliminary observations
using functional MRI. Am J Psychiatry 2003;160:1345-1347
Chambers RA, Potenza MN, Hoffman RE, Miranker W. Simulated
apoptosis/neurogenesis regulates learning and memory of adaptive multilayer
neural networks. Neuropsychopharmacol (in press) http://www.acnp.org/citations/NPP10230303327/default.pdf
Cavus I, Abi-Saab WM, Zavery H, Cassaday M, Spencer DD, Sherwin RS, Krystal
J. Cognitive stimulation increases extracellular glutamate, glucose, and
lactate levels and modulates theta activity. A microdialysis and hippocampal
depth electrode study in awake behaving humans. Biol Psychiatry 2002;51:160S
(#469)
Corbin, W.R., Roth, J., & Fromme, K. Stimulant alcohol effects prime
loss of control drinking. Experimental and Clinical Psychopharmacology.(submitted)
Covault J, Gelernter J, Hesselbrock V, Nellissery M, Kranzler HR: Allelic and haplotypic association of GABRA2 with alcohol dependence. Am J Med Genet. 2004;129B:104-109
Cramer J, Rosenheck R, Kirk G, Krol W, Krystal JH (and the VA Naltrexone
Study Group 425). Usefulness of a compliance feedback and monitoring program
in a multicenter treatment trial. Value in Health 2003; 6: 566-573.
Daurignac E., Krishnan-Sarin S., OMalley S.S., Krystal J.H., Ford J.M.,
Mathalon D.H. Effects of family history and gender on P300 in alcohol
dependence. Abstract RSA 2004.
Desai RA, Maciejewski PK, Dausey DJ, Caldarone BJ, Potenza MN Health
correlates of recreational gambling in older adults. Am J Psychiatry(in
press)
D'Souza DC, Gil R, MacDougall L, Cassello K, Boutros N, Innis RB, Krystal
JH. GABA serotonin interactions in healthy subjects: implications for
psychosis and dissociation. Neuropsychopharmacology in revision.
Epperson CN, Mason GF, Haga K, Appel M, Sellers E, Gueorguieva R, Rothman
D, Krystal JH. Differential menstrual cycle-related fluctuations in cortical??-aminobutyric
acid levels in women with premenstrual dysphoric disorder (PMDD) and healthy
menstruating women: a 1H-MRS study.Arch Gen Psychiatry 2002;59:851-858
Epperson CN, O'Malley S, Czarkowski K, Gueorguieva R, Rothman DL, Sanacora
G, Krystal JH, Mason GP. Sex, GABA, and nicotine: the impact of smoking
and menstrual cycle phase on cortical GABA levels measured with 1H-MRS.
Biol Psychiatry in review.
Epperson CN, Cappiello A, Czarkowski K, Stiklus S, Wasylink S, Anderson
G, Heninger G, Charney DS, Krystal JH. Effects of estrogen on depressive
relapse after tryptophan depletion in remitted depressed menopausal women.
In review
First, MB, Bell C, Cuthbert B, Krystal J, Malison R, Offord D, Reiss
D, Shea T, Widiger T, Wisner K. Personality disorders and relational disorders:
a research agenda for addressing crucial gaps in DSM. APA Research Agenda
for DSM-V. Kupfer DJ, First MB, Regier DA (eds), American Psychiatric
Association: Washington, D.C., 2002;123-199
Fromme, K. & Corbin, W.R. Prevention of heavy drinking and associated
negative consequences among mandated and voluntary college students. Journal
of Consulting and Clinical Psychology. (In Press).
Fromme, K., deWit, H., Hutchinson, K.E., Ray, L., Corbin, W.R., Cook,
T.A., Wall, T.L., & Goldman, D. Biological and behavioral markers
of alcohol sensitivity. Alcoholism: Clinical and Experimental Research.
(In Press).
Gelernter J, Liu X, Hesselbrock V, Page GP, Goddard A, and Zhang H: Results
of a genomewide linkage scan: Support for chromosomes 9 and 11 loci increasing
risk for cigarette smoking. In press, Am J Med Genet (Neuropsych Genet) 2004;128B, 94-101
Gelernter J, Page GP, Stein MB, and Woods SW: Genomewide linkage scan
for loci predisposing to social phobia: evidence for a chromosome 16 risk
locus. In press, American Journal of Psychiatry
Goddard AW, Mason G, Rothman DL, Behar KL, Krystal JH. Influence of medication
and family history on cortical GABA levels in panic disorder. Biol Psychiatry
2002;51:48S (#143)
Goddard AW, Mason GF, Rothman DL, Behar KL, Krystal JH. Reduced cortical
GABA neuronal response to benzodiazepine administration in panic disorder.
Am J Psychiatry in press
Gueorguieva R, Krystal JH. Move over ANOVA: Progress in analytic methods
for repeated measures data from psychiatric clinical trials. Arch Gen
Psychiatry in revision.
Jacobsen LK, Gore JC, Skudlarski P, Lacadie CM, Jatlow P, Krystal JH:
Impact of intravenous nicotine on BOLD signal response to photic stimulation,
Magnetic Resonance Imaging 2002;20:141-145
Jacobsen LK, Pugh KR, Mencl WE, Skudlarksi P, Krystal JH. Preliminary
evidence of hippocampal dysfunction in adolescent MDMA ('Ecstasy') users:
possible relationship to neurotoxic effects. Psychopharmacology In press.
Jacobsen LK, Krystal JH, Mencl WE, Westerveld M, Frost SJ, Pugh KR. Effects
of smoking and smoking abstinence on cognition in adolescent tobacco smokers.
In review.
Kaufman J, Yang B-Z, Douglas-Palumberi H, Houshyar S, Lipschitz D, Krystal JH, Gelernter J. Social supports and serotonin transporter gene moderate depression in maltreated children. Proc Nat Acad Sci USA In press.
Krishnan-Sarin S, George TP, O'Connor PG, O'Malley S. HPA axis responsivity:
differential changes produced by alcohol and/or nicotine dependence. in
symposium: Stress-Axis Reactivity to Pharmacologic Challenges: Defining
the Disruption in the Drinkers and their Kids. Abstract RSA 2004
Krishnan-Sarin, S., Shi, J., M.D., Reutenauer, E., B.S., Bathey, S.,
Grant, C., Thoni, S., Zhang, J., Krystal, J., O'Malley, S. Individual
differences in alcohol self-administration behavior. Symposium at RSA
2004
Krishnan-Sarin, S., Shi, J., Duhig, A., Cramer, J., Zhang, J., Krystal,
J., O'Malley, S.S. Response in the Color-Word Stroop task: Influence of
Family history of alcoholism, alcohol administration and Naltrexone. Poster
at RSA 2004
Krystal J. Detoxification and Initiation of Abstinence from Alcohol Comparing
Gabapentin, Valproic Acid and Placebo Augmentation of Benzodiazepine Escape.
Alc Clin Exp Res 2003; 27(5); 148A (#857)
Krystal JH, Abi-Saab W, Perry E, D'Souza DC, Liu N, McDougall L, Belger
A, Levine L, Breier. Modulation of ketamine-induced working memory deficits
in healthy human subjects by the group II metabotropic agonist, LY354740.
American College of Neuropsychopharmacology, 41th Annual Meeting, San
Juan, Puerto Rico, December 9-13, 2002 abstract
Krystal JH, Abi-Saab W, Perry E, D'Souza DC, Liu N, Gueorguieve R, McDougall
L, Hunsberger T, Belger A, Levine L, Breier A. Preliminary evidence of
attenuation of the disruptive effects of the NMDA glutamate receptor antagonist,
ketamine, on working memory by pretreatment with the the group II metabotropic
glutamate receptor (mGluR) agonist, LY354740, in healthy human subjects.
Psychopharmacology in press.
Krystal JH, Cramer JA, Rosenheck R, and the VA Naltrexone Study Group
425. What predicts response to treatment? Alc Clin Exp Res 2002;26(5):86A
(#487)
Krystal JH, Petrakis I, Limoncelli D, Webb E, Gueorgueva R, D'Souza DC,
Boutros NN, Trevisan L, Charney DS. Altered NMDA Glutamate Receptor Antagonist
Response in Recovering Ethanol Dependent Patients. Alc Clin Exp Res 2003;
27(5); 19A (#79)
Krystal JH, Petrakis I, Limoncelli D, Webb E, Gueorgueva R, Trevisan
L, Boutros NN, D'Souza DC. Impact of Family Alcohol Dependence History
Upon NMDA Receptor Function in Recovering Alcohol Dependent Patients.
Alc Clin Exp Res 2003; 27(5); 46A (#246)
Krystal JH, Petrakis IL, Krupitsky E, Schütz C, Trevisan L, D'Souza
DC. NMDA Receptor Antagonism and the Ethanol Intoxication Signal: From
Alcoholism Risk to Pharmacotherapy. Ann NY Acad Sci, 2003; 1003: 176-184.
Krystal JH, Petrakis IL, Limoncelli D, Webb E, Gueorgueva R, D'Souza
DC, Boutros N, Trevisan L, Charney DS. Altered NMDA glutamate receptor
antagonist response in recovering ethanol dependent men. Neuropsychopharmacology
2003;28:2020-2028
Krystal JH, Petrakis IL, Mason G, D'Souza DC. NMDA glutamate receptors
and alcoholism: reward, dependence, treatment, and vulnerability. Pharmacol
Therapeutics in press.
Krystal JH, Petrakis IL, Mason G, Trevisan L, D'Souza DC. NMDA Glutamate
Receptors and Alcoholism: Reward, Dependence, Treatment, and Vulnerability.
Pharmacology & Therapeutics 99, 2003; 79-94.
Krystal JH, Petrakis IL, Trevisan L, D'Souza DC. NMDA receptor antagonism
and the ethanol intoxication signal: From alcoholism risk to pharmacotherapy.
Annals NY Academy of Science, in press.
Krystal JH, Rosenheck R, Cramer J, and the VA Naltrexone Study Group
425. Relapse to heavy drinking during and after treatment in the VA mulicenter
naltrexone trial. Alc Clin Exp Res 2002;26(5):86A (#486)
Krystal JH, Sanacora G, Blumberg H, Anand, A, Charney DS, Marek G, Epperson
CN, Goddard A, Mason GF. Glutamate and GABA systems as targets for novel
antidepressant and mood stabilizing treatments. Mol Psychiatry 2002;7:S71-S80
Krystal JH. First, do no harm; then, do some good: ethics and human psychopharmacology.
Israel Journal of Psychiatry and Related Sciences 2002;39(2):89-91
Krystal, JH., Petrakis, IL., D'Souza, D. C., Mason, G., Trevisan, L.
Alcohol and glutamate neurotransmission in humans: implications for reward,
dependence, and treatment. In: Glutamate and addiction. Herman BH, Frankenheim
J, Litten RZ, Sheridan PH, Weight FF, Zukin SR (eds), Totowa, NY: Humana
Press, 2002; in press.
Lappalainen J, Kranzler HR, Malison R, Price LH, Van Dyck C, Rosenheck
RA, Cramer J, Southwick SM, Charney DS, Krystal JH, Gelernter J. A functional
neuropeptide Y Leu7Pro polymorphism is associated with alcohol dependence
in a large American population sample. Arch Gen Psychiatry 2002;59:825-831
Lappalainen J, Kranzler HR, Petrakis IL, Somberg LK, Page G, Krystal JH,
Gelernter JE. Fine mapping of the chromosome 1 alcoholism risk locus.
Mol Psychiatry in press.
Lappalainen J, Kranzler HR, Petrakis IL, Somberg LK, Page G, Krystal
JH, Gelertner, J. Confirmation and Fine-Mapping of the Chromosome 1 Alcohol
Dependence Risk Locus, Molecular Psychiatry, in press.
Lappalainen J, Krupitsky E, Remizov M, Pchelina S, Taraskina A, Zvartau E Somberg LK, Covault J, Kranzler HR, Krystal JH, and Gelernter J: Association between alcoholism and GABRA2 in a Russian population. Alc Clin Exp Res (in press)
Lappalainen J, Sanacora G, Kranzler HR, Malison R, Hibbard ES, Price
LH, Krystal JH, Gelernter J. Mutation screen of the glutamate decarboxylase-67
gene and haplotype association to unipolar depression. Neuropsychiatric
Genetics in press.
Luo X, Kranzler HR, Zhao H, and Gelernter J: Haplotypes at the OPRM1
locus are associated with susceptibility to substance dependence in European
Americans. Am J Med Genet (Neuropsych Genet) 120B:97 108, 2003
Mason GF, Appel M, de Graaf RA, Petrakis I, Ruff E, Rothman DL, Krystal
JH (2003) Brain GABA falls by 1 month of detoxification and remains low.
Research Society on Alcoholism (in press : June 2003) -- oral presentation
Mason GF, Appel M, de Graaf RA, Petrakis I, Ruff E, Rothman DL, Krystal JH (2003) Brain GABA falls by 1 month of detoxification and remains low. Alc Clin Exp Res 2004: 27:48A.
Mason GF, Appel M, de Graaf RA, Ruff E, Rothman DL, Krystal JH (2003)
Brain GABA falls with sobriety in alcohol-dependent subjects. Proceedings
of the International Society of Magnetic Resonance in Medicine (in press
: May 2003) -- oral presentation
Mason GF, Petrakis IL, de Graaf RA, Appel M, Gueorguieva R, Ruff E, Coric
V, Epperson CN, Rothman DL, Krystal JH. Cortical GABA levels and the recovery
from alcohol dependence: relationship to neurotoxicity and cigarette smoking.
In Review.
Mason GF, Appel M, de Graaf RA, Petrakis I, Ruff E, Rothman DL, Krystal
JH, Reduction in Cortical GABA Levels Over the First Month of Sobriety.
Alc Clin Exp Res 2003; 27(5); 56A (#305)
Mason GF, Petrakis IL, Haga K, Frisbee R, Appel M, Rothman DL, Krystal
JH. Preliminary evidence of decreased cortical GABA in patients during
alcohol detoxification. Alc Clin Exp Res 2002;26(5):105A (#599)
Mason GF, Sibson NR, Behar KL, Hyder F, Sze A, Shulman RG, Rothman DL
(2002) Nicotine increases the rate of glutamate-glutamine cycling and
glucose oxidation in rat brain in vivo. American College of Neuropsychopharmacology,
San Juan, Puerto Rocio, December 7-13th.
Mathalon, D.H., and Ford, J.M. (2002). The long and the short of it:
Influence of interstimulus interval on auditory P300 abnormalities in
schizophrenia. Clinical EEG, 33(3), 125-135.
Mathalon, D.H., Pfefferbaum, A., Lim, K.O., Rosenbloom, M.J., Sullivan,
E.V. (2003). Compounded brain volume deficits in schizophrenia-alcoholism
comorbidity. Archives of General Psychiatry, 60, 245-252.
McClung, C.A. and Nestler, E.J. (2003) Regulation of gene expression
and cocaine reward by CREB and ?FosB. Nature Neurosci. 11:1208-1215.
Morgan CA III, Krystal JH, Southwick SM. Toward early post-stress pharmacotherapeutic
intervention. Biol Psychiatry in press.
Nellissery M, Feinn RS, Covault J, Gelernter J, Anton RF, Pettinati H,
Moak D, Mueller T, and Kranzler HR: Alleles of a Functional Serotonin
Transporter Promoter Polymorphism Are Associated With Major Depression
in Alcoholics. In press, Alcohol: Clinical and Experimental Research
Neuroscience. 2002; 3(12):29-36
Nich C, McCance-Katz EF, Petrakis IL, Cubells JF, Rounsaville BJ. Sex
Differences in Cocaine Dependent Individual's Response to Disulfiram Treatment,
Addictive Behaviors, in press.
Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, Volpicelli
JR, and O'Brien CP: A fu nctional polymorphism of the µ-opioid receptor
gene is associated with naltrexone response in alcohol-dependent patients.
Neuropsychopharmacology. 28(8):1546 52, 2003
Owens, J.C., Balogh, S.A., McClure-Begley, T.D., Labarca, C., Lester,
H.A., Picciotto, M.R., Wehner, J.M. and Collins, A.C. (2003) a4b2*-type
neuronal nicotinic receptors modulate the effects of nicotine and ethanol
on the acoustic startle response. Alc Clin Exp Res, 27(12):1867-75.
Peakman, M.C., Colby, C., Perrotti, L.I., Tekumalla, P., Carle, T., Ulery,
P., Chao, J., Duman, C., Steffen, C., Monteggia, L., Allen, M.R., Stock,
J.L., Duman, R.S., McNeish, J.D., Barrot, M., Self, D.W., Nestler, E.J.,
and Schaeffer, E. (2003) Inducible, brain region specific expression of
a dominant negative mutant of c-Jun in transgenic mice decreases sensitivity
to cocaine. Brain Res. 970:73-86.
Petrakis IL, Naltrexone and/or Disulfiram for Alcohol Dependent Veterans
with Comorbid Mental Disorders. Alc Clin Exp Res 2003; 27(5); 176A (#81)
Petrakis IL, Trevisan L, O'Malley S, Vuppalapati D, Hould J, Limoncelli
D, Krystal J. Gelatin "shots", an Alternative Method of Alcohol
Administration in the Laboratory. Alc Clin Exp Res 2003; 27(5); 157A (#908)
Petrakis IL, Buonopane A, O'Malley S, Cermik O, Trevisan L, Boutros NN,
Limoncelli D, Krystal JH. The effect of tryptophan depletion on alcohol
self-administration in non-treatment seeking alcoholic individuals. Alc
Clin Exp Res 2002;26(7):969-975
Petrakis IL, Gonzalez-Haddad G, Rosenheck R, Krystal JH. Comorbidity
of alcoholism and psychiatric disorders. Alcohol Research and Health 2002;26:81-89
Petrakis IL, Leslie D, Rosenheck R, The use of antidepressants in alcohol
dependent veterans, Journal of Clinical Psychiatry, 2003; 64(8): 865-870.
Petrakis IL, O'Malley S, Rounsaville B, Poling J, McHugh-Strong C, Krystal
JH. Naltrexone augmentation of neuroleptic in alcohol-abusing schizophrenic
patients. Psychopharmacology in press
Petrakis IL, Limoncelli D, Gueorguieva R, Boutros NN, Trevisan L, Gelernter
J, Krystal JH. Altered NMDA glutamate receptor antagonist response in
individuals with a familial vulnerability to alcoholism. Am J Psychiatry 2004; 161:1776-1782
Potenza, M.N., Brodkin, E.S., Luo, X.G., Remmers, EF, Nestler, E.J.,
and Gelernter, J. (2003) Genomic regions controlling corticosterone levels
in rats. Biol. Psychiatry, in press.
Potenza MN, Xian H, Shah KR, Scherrer JF, Eisen SA Shared genetic contributions to pathological gambling and major depression in men. Arch Gen Psychiatry (in press).
Rosenheck R, Krystal JH, Cramer J, and VA Naltrexone Study Group 425.
Effect of low and high participation in counseling on drinking cessation.
Alc Clin Exp Res 2002;26(5):129A (#745)
Schütz CG, Mayer C, Koller G, Wernicke M, Gueorguieva R, Krystal
JH. Combining naltrexone and memantine to block the rewarding effects
of alcohol-an experimental pilot study in human subjects. Alc Clin Exp
Res 2002;26(5):130A (#750)
Skolnick P, Krystal JH. Depression. In: Therapeutic potential of glutamate
receptor antagonists and modulators. D. Lodge, W. Danysz, C.G. Parsons
(Eds.). F.P. Graham and Company: Johnson, TN, 2002;71-90
Sofuoglu M, Singha A, Kosten TR,, McCance-Katz FE, Petrakis IL, Oliveto
A. Effects of naltrexone and isradipine, alone or in combination, on cocaine
responses in humans. Pharmacology Biochemistry and Behavior, 2003; 75:
801-808.
Staley JK, Gottschalk PC, Petrakis I, Zoghbi S, Verhoeff NP, Seibyl JP,
Van Dyck C, Innis RB, Krystal JH. Cortical GABA-A receptors and the recovery
from alcohol dependence: relationship to clinical features of alcohol
dependence and cigarette smoking. In review.
Staley JK, Gottschalk PC, Petrakis I, Zoghbi S, Verhoeff NP, Seibyl JP,
Van Dyck C, Innis RB, Krystal JH. Assessment of cortical benzodiazepine-GABA-A
receptors in recovering alcoholics over the first month of sobriety. Alc
Clin Exp Res 2002;26(5):68A
Staley JK, Mason G, Gottschalk PC, Petrakis I, Zoghbi S, Verhoeff NP,
Seibyl JP, Van Dyck C, Innis RB, Baldwin RM, Krystal JH (2002) GABAergic
dysfunction in recovering alcoholics. Proceeedings of the German Society
of Addiction Research Therapy, Berlin, Germany, April 2002
Staley JK, Mason G, Petrakis I, Zoghbi SS, Verhoeff NP, Seibyl JP, Van
Dyck C, Innis RB, Baldwin RM, Krystal JH (2002) Assessment of cortical
GABA fuynction in acutely (< 7 days) detoxified alcohol dependent subjects.
Society of Nuclear Medicine, Los Angeles, CA, June 2002
Staley JK, Petrakis I, Gottschalk PC, Ruff E, Frohlich E, Weinzimmer
D, Seibyl JP, VanDyck C, Baldwin RM, Krystal JH. Iomazenil SPECT Imaging
Demonstrates No Change in Cortical Benzodiazepine GABA-A Receptors in
Long Term Sober Alcoholics. Alc Clin Exp Res 2003; 27(5); 20A (#90)
Staley JK, Petrakis I, Gottschalk PC, Zoghbi S, Verhoeff NP, Seibyl JP,
Vandyck C, Innis RB, Baldwin RM, Krystal JH. Alterations in GABA-A receptor
binding in ethanol dependence: clinical correlates. Soc Neurosci Abstr
2002;28:899.12
The COMBINE Study Research Group (including J. Krystal). Testing combined
pharmacotherapies and behavioral interventions in alcohol dependence:
rationale and methods. Alcohol Clin Exp Res 2003;27:1107-1122
Stein MB , Schork MJ, and Gelernter J: A polymorphism of the β1-adrenergic receptor is associated with low extraversion. Biological Psychiatry 2004;56:217-224
van Dyck, C. H., Malison, R. T., Staley, J. K., Jacobsen, L. K., Seibyl,
J. P., Laruelle, M., Baldwin, R. M., Innis, R. B., & Gelernter, J.
(in press). Central serotonin transporter availability measured with [123I]ß CIT SPECT in relation to serotonin transporter genotype. Am. J. Psychiat (in press)
Waterhouse R, Slifstein M, Dumont F, Sultana A, Balter AI, Sudo Y, Laruelle
M: In vivo evaluation of [11C]n-(2-chloro-5-thiomethylphenyl)-n'-(3-methoxy-phenyl)-n'-methylguanidine
([11C]GMOM) as a potential PET radiotracer for the PCP/MNDA receptor.
Submitted 2004
Yang BZ, Zhao H, Kranzler HR, Gelernter J: Practical population group assignment with selected informative markers: characteristics and properties of Bayesian clustering via STRUCTURE. Genetic Epidemiology 2005;25:1-11; DOI: 10.1002/gepi.20070
|